Novartis AG (NVS)

163.92 -1.46 (-0.88%) USD  |  NYSE  |  Feb 19, 16:00
162.68 -1.24 (-0.76%) Pre-Market: 08:36
More

Novartis Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for NVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Roche Holding AG Upgrade
Amgen, Inc. Upgrade
AstraZeneca PLC Upgrade
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade